We are live on
!
Find out more
GAA
Green Alpha Advisors Portfolio holdings
AUM
$148M
Turnover
14.17%
1-Year Est. Return
98.22%
This Fund
S&P 500
This Quarter
Est. Return
+21.29%
1 Year Est. Return
+98.22%
3 Year Est. Return
+315.88%
5 Year Est. Return
+340.2%
10 Year Est. Return
–
AUM
$105M
AUM Growth
+$11.1M
(+12%)
Cap. Flow
-$4.32M
Cap. Flow
% of AUM
-4.13%
Top 10 Holdings %
Top 10 Hldgs %
37.08%
Holding
112
New
–
Increased
5
Reduced
104
Closed
3
Avg Time Held
3.2
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Horizon Technology Finance
HRZN
|
+$226K |
| 2 |
Moderna
MRNA
|
+$68.4K |
| 3 |
Vail Resorts
MTN
|
+$49.5K |
| 4 |
CRISPR Therapeutics
CRSP
|
+$42.6K |
| 5 |
Steelcase
SCS
|
+$38.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Twist Bioscience
TWST
|
+$238K |
| 2 |
Tempus AI
TEM
|
+$226K |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$218K |
| 4 |
Vitamin Cottage Natural Grocers
NGVC
|
+$209K |
| 5 |
Radius Recycling
RDUS
|
+$179K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 52.13% |
| 2 | Healthcare | 12.72% |
| 3 | Consumer Staples | 11.23% |
| 4 | Consumer Discretionary | 7.41% |
| 5 | Industrials | 6.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
AXS Green Alpha ETF
NXTE
$47.8M
| $380K | 0.36% |
11,178
-2,175
| -16% | -$67.5K |
2022 Q3
11 quarters
|
|
77
Editas Medicine
EDIT
$366M
| $376K | 0.36% |
170,782
-13,121
| -7% | -$21.5K |
2020 Q4
18 quarters
|
|
78
T1 Energy
TE
$779M
| $374K | 0.36% |
304,026
-16,360
| -5% | -$19.9K |
2022 Q2
12 quarters
|
|
79
California Water Service
CWT
$2.86B
| $357K | 0.34% |
7,849
-586
| -7% | -$28K |
2020 Q4
18 quarters
|
|
80
Yeti Holdings
YETI
$3.14B
| $356K | 0.34% |
11,304
-796
| -7% | -$23.9K |
2023 Q3
7 quarters
|
|
81
Skyworks Solutions
SWKS
$18.7B
| $353K | 0.34% |
4,739
-327
| -6% | -$21.8K |
2020 Q4
18 quarters
|
|
82
Butterfly Network
BFLY
$1.94B
| $350K | 0.33% |
175,116
-11,192
| -6% | -$25.7K |
2023 Q3
7 quarters
|
|
83
Array Technologies
ARRY
$524M
| $344K | 0.33% |
58,251
-3,606
| -6% | -$21.9K |
2021 Q2
16 quarters
|
|
84
Arcturus Therapeutics
ARCT
$298M
| $338K | 0.32% |
25,982
-1,249
| -5% | -$14.8K |
2025 Q1
1 quarter
|
|
85
Guardant Health
GH
$21.2B
| $286K | 0.27% |
5,494
-1,436
| -21% | -$64.1K |
2024 Q2
4 quarters
|
|
86
Azenta
AZTA
$1.48B
| $264K | 0.25% |
8,580
-594
| -6% | -$16.7K |
2020 Q4
18 quarters
|
|
87
10x Genomics
TXG
$9.03B
| $260K | 0.25% |
22,456
-1,514
| -6% | -$13.8K |
2024 Q4
2 quarters
|
|
88
Pacific Biosciences
PACB
$532M
| $257K | 0.25% |
207,023
-9,771
| -5% | -$11.3K |
2021 Q2
16 quarters
|
|
89
Vertex Pharmaceuticals
VRTX
$126B
| $252K | 0.24% |
565
-103
| -15% | -$47.5K |
2021 Q1
17 quarters
|
|
90
American Water Works
AWK
$26.8B
| $245K | 0.23% |
1,758
-294
| -14% | -$42.1K |
2021 Q2
16 quarters
|
|
91
Intuitive Surgical
ISRG
$151B
| $235K | 0.22% |
433
-96
| -18% | -$50.2K |
2022 Q2
12 quarters
|
|
92
Personalis
PSNL
$1.67B
| $209K | 0.2% |
31,839
-5,444
| -15% | -$25.3K |
2021 Q2
16 quarters
|
|
93
Remitly
RELY
$5.06B
| $200K | 0.19% |
10,668
-2,469
| -19% | -$51.4K |
2024 Q3
3 quarters
|
|
94
Prime Medicine
PRME
$635M
| $195K | 0.19% |
78,994
-4,473
| -5% | -$6.89K |
2024 Q4
2 quarters
|
|
95
Fluence Energy
FLNC
$843M
| $184K | 0.18% |
27,432
-841
| -3% | -$4.01K |
2023 Q3
7 quarters
|
|
96
DELISTED
TPI Composites
TPIC
| $180K | 0.17% |
209,415
-3,253
| -2% | -$3.31K |
2020 Q4
18 quarters
|
|
97
Ginkgo Bioworks
DNA
$687M
| $178K | 0.17% |
15,832
-2,638
| -14% | -$20.4K |
2023 Q1
9 quarters
|
|
98
ECARX Holdings
ECX
$342M
| $142K | 0.14% |
69,222
-9,459
| -12% | -$13.7K |
2024 Q4
2 quarters
|
|
99
SOPHiA GENETICS
SOPH
$581M
| $133K | 0.13% |
42,906
-4,172
| -9% | -$12.4K |
2024 Q3
3 quarters
|
|
100
Inovio Pharmaceuticals
INO
$104M
| $108K | 0.1% |
53,308
-7,953
| -13% | -$15.2K |
2021 Q2
16 quarters
|
|
Similar funds
BM
LFWA
RLWM
ACM
BSTWA
NI
TWPM
AA
Green Alpha Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Green Alpha Advisors held 112 positions worth $105M, up 12% from $93.6M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Green Alpha Advisors withdrew a net $4.32M in Q2 2025, closing 3 positions and reducing 104 holdings. Its most notable exit was Twist Bioscience, an estimated $238K position sold in full.
By sector, the portfolio is most concentrated in Technology at 52% of assets, up from 50% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Green Alpha Advisors added an estimated $226K to Horizon Technology Finance.
- Green Alpha Advisors added most to Horizon Technology Finance in Q2 2025, an estimated $226K increase.
- Green Alpha Advisors's biggest Q2 2025 reduction was Tempus AI, cutting an estimated $226K.
- Green Alpha Advisors fully exited Twist Bioscience in Q2 2025, selling an estimated $238K.
- Green Alpha Advisors's ten largest holdings make up 37% of its $105M portfolio in Q2 2025.
- Green Alpha Advisors opened 0 new positions and closed 3 in Q2 2025.
- Green Alpha Advisors's portfolio value rose 12% quarter-over-quarter to $105M.
Based on Green Alpha Advisors's 13F filing for Q2 2025, filed 1 Aug 2025.